0.00Open0.10Pre Close0 Volume334 Open Interest180.00Strike Price0.00Turnover332.99%IV135.67%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.10Extrinsic Value100Contract SizeAmericanOptions Type0.0120Delta0.0012Gamma764.20Leverage Ratio-0.0731Theta0.0001Rho9.15Eff Leverage0.0025Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet